Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Express Scripts

Last Updated: June 28, 2022

Details for Patent: 6,641,843

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,641,843
Title: Pharmaceutical compositions
Abstract:The present invention relates to pharmaceutical compostions of (1S,4R)-cis-4-[2-amino-6-cyclopropylamino}-9H-purin-9-yl]-2-cyclopentene-1 -methanol (1592U89).
Inventor(s): Brooks; Nikki Thoennes (Glen Allen, VA)
Assignee: SmithKline Beecham Corporation (Philadelphia, PA)
Application Number:09/601,671
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Process; Formulation;

Drugs Protected by US Patent 6,641,843

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,641,843

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9802472Feb 06, 1998
PCT Information
PCT FiledFebruary 04, 1999PCT Application Number:PCT/EP99/00663
PCT Publication Date:August 12, 1999PCT Publication Number: WO99/39691

International Family Members for US Patent 6,641,843

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 1212 See Plans and Pricing
Argentina 017455 See Plans and Pricing
Austria 237309 See Plans and Pricing
Australia 2722199 See Plans and Pricing
Australia 754255 See Plans and Pricing
Brazil 9907649 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.